Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001086366 | SCV000831734 | likely benign | Intellectual disability, CASK-related, X-linked | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000733420 | SCV000861488 | uncertain significance | not provided | 2018-06-07 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000990800 | SCV001141839 | likely benign | Syndromic X-linked intellectual disability Najm type | 2020-05-06 | criteria provided, single submitter | clinical testing | This variant, that leads to the substitution of proline in codon 396 for serine, has been previously reported in medical literature to segregate with the phenotype of X-linked intellectual deficiency in one family (PMID: 19377476). However, functional studies demonstrate that it results in a structurally stable protein and interactions with liprin-α, Mint-1 and Veli are preserved (PMID: 24505460). In addition, it is observed at a higher than expected frequency in population databases, including 5 hemizygous individuals (gnomAD v2.1.1). Therefore, this variant was considered to be likely benign. |
Gene |
RCV000733420 | SCV001793621 | likely benign | not provided | 2020-02-14 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 19377476, 23871722, 33090494, 24505460, 21954287, 22452838, 19847910, 21735175, 29426960, 25886057, 20029458) |
Ambry Genetics | RCV002326675 | SCV002634078 | likely benign | Inborn genetic diseases | 2018-01-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000733420 | SCV004702339 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | CASK: BS2 |
OMIM | RCV000012292 | SCV000032526 | pathogenic | FG syndrome 4 | 2009-05-01 | no assertion criteria provided | literature only |